From the viewpoint of T-cell receptor (TCR) repertoire, we studied the role of T cells in acute graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (allo-BMT) from an HLA-identical sibling. By means of inverse polymerase chain reaction method and DNA sequencing, we analyzed TCR-(r and -p transcripts from GVHD lesions and peripherat blood (PB) in a patient with typical GVHD together with PB from donor. At the initial onset of GVHD, Vu-7 and -19 subfamilies were oligoclonally expanded in the PB compared with those in the oral mucosal lesions. At the second onset, Va-2, and Vfi-6 subfamilies were more fre-CUTE graft-versus-host disease (GVHD) is a major complication after allogeneic bone marrow transplantation (~~O -B M T ) . ' *~ T cells may play a key role in acute GVHD, as suggested by the following: the number of transfused T cells correlated with the severity of GVHD3; acute GVHD is efficiently prevented by T-cell depletion from donor BM before transplantation4; and T cells infiltrate GVHD lesions?Z6 T cells are developmentally selected to recognize self major histocompatibility complex (MHC) molecules in the thymus, and consequently two major subsets of CD4+CD8-and CD4-CD8+ T cells recognize peptide-antigens in association with class I1 and class I MHC molecules, respectively.' In HLA-mismatched allo-BMT, severe GVHD usually occurs, and allo-reactive T cells have been detected in the circulation.' The recognition of allo-MHC molecules has been thought to result from the similarity of the determinant expressed by allo-MHC molecule with that created by the self-MHC and peptide complex.' A considerable percentage of normal peripheral T cells are reportedly allo-reactive."
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In HLA-identical allo-BMT, although acute GVHD remains an important clinical issue, the molecular and cellular mechanism has not been well elucidated. Minor histocompatibility antigens (minHAs) are likely targets of allo-recognition in acute GVHD after BMT as well as in graft rejection after HLA-identical organ
The minHAs have been recognized not by serological experiments but occasionally by T-cell function t e s t~, l~* '~ suggesting that min-HAS consist of various peptides bound to MHC. Most of these minHAs have been defined by MHC class I-restricted cytotoxic T-lymphocyte clones established from patients with acute GVHD after allo-BMT from an HLA-identical ~i b l i n g . '~"~ Recently, one of the minHAs, HA-2, has been molecularly identified. The sequence of the HLA-A2.1-bound peptide was significantly homologous to nonfilamentous class 1 myosins. 16 One approach for the better understanding of acute GVHD is to characterize the infiltrating T cells in the GVHD lesions. blood (PB) have been analyzed by reverse transcriptasepolymerase chain reaction (RT-PCR) using V-subfamilyspecific primers and a constant (C) region primer, and selectively amplified T-cell transcripts were supposed to be involved in acute GVHD after HLA-identical ~~~O -B M T . " . '~ In this study, we analyzed TCR-(Y and -0 transcripts from GVHD lesions and PB in a patient with typical GVHD together with PB from donor, by means of inverse PCR method and DNA sequencing. To determine whether particular TCR sequences are associated with GVHD, we analyzed TCR transcripts in three different GVHD lesions from the patient on two different occasions, and compared them with those in the patient's PB before allo-BMT and at times of GVHD onset as well as those in the donor PB.
MATERIALS AND METHODS

Patient.
A 47-year-old woman in the chronic phase of chronic myeloid leukemia received BM from an HLA-identical sibling in 1992. The HLA allotype was A24, -; B54, -; Cwl, -; DR4, -; DQ4, -. Busulfan (1 mgkg X 4 timedd) was administered orally for consecutive 4 days followed by intravenous administration of cyclophosphamide (60 mgkgld) for 2 days as a conditioning regimen. For GVHD prophylaxis, a combination of short-term methotrexate and cyclosporin A was administered as described.'' Oral mucositis developed on day 49 and an erythematous rash appeared on the face and neck on day 96. After informed consent was obtained from the patient, mucosal biopsies were performed from the inside of lower lip and the left buccal membrane on day 52, and a skin biopsy sample was taken from the neck on day 97. Each biopsied material was divided into three pieces and used for analyses described below. Grade I of acute GVHD was diagnosed, and she received prednisolone (0.6 mg/kg/d) from day 52 in addition to cyclosporin A (3 mg/kg/d).
Histostaining of the GVHD lesions. One piece of each material was fixed with 10% formalin and embedded in paraffin for hematoxylin-eosin (HE) staining. The second piece was fixed with 4% paraformaldehyde and snap frozen. Consecutive cryostat sections were prepared for peroxidase-labeled streptavidin-biotin staining (DAKOJapan, Kyoto, Japan) using the following antibodies: Leu4 (CD3), Leu3 (CD4). and Leu2 (CD8) (Becton Dickinson, San Jose, CA). Peroxidase activity was detected using 3, 3'-diaminobenzidine as a chromogen with H202 as a substrate. The sections were counterstained with hematoxylin.
Inverse PCR amplification of TCR transcripts. Total cellular RNA was extracted from PB mononuclear cells and the third piece of the biopsied material which was homogenized in a Microtubehomogenizer (Cosmo Bio. Cop, Tokyo, Japan) using RNAzol B (Biotecx Laboratories Inc, Houston, TX) according to the manufacturer's recommendations. Double-stranded cDNA was synthesized from 1 pg of total RNA using a cDNA synthesis kit (Boehringer Mannheim, Mannheim, Germany), containing T4 DNA polymerase for blunt end-formation. The double-stranded cDNA was circularized by incubation with 1 U of T4 DNA ligase (GIBCOBRL, Grand Island, NY) at room temperature for 1 hour as previously described." Onetenth of the circularized cDNA was used as a template for the first step amplification with 300 nmol/L of the outward directed C region primers described below. PCR was performed with Taq DNA polymerase and recommended assay buffer (Promega, Madison, WI) at 2 mmoVL Mg2+ concentration for 30 cycles on a thermal cycler (Astec, Fukuoka, Japan). The amplification cycle consisted of denaturation at 93°C for 1 minute, annealing at 57°C for 1.5 minutes, and extension at 72°C for 1.5 minutes. One tenth of the PCR product was used for the second step of PCR and amplified for 15 cycles. Denaturation, annealing, and extension proceeded at 93°C for 1 minute, at 68°C for 1 minute, at 72°C for 1.5 minutes, respectively. PCR products were separated by electrophoresis on a 5% polyacrylamide gel, and DNA fragments of the expected sizes were removed from the gels by the crush and soak procedure. Recovered DNA fragments were digested with Sal I and Not I restriction endonucleases for cloning into vectors.
Oligonucleotide primers were synthesized using an automated DNA synthesizer (model 381-A; Applied Biosystems, Foster City, CA). Primers for the first step of TCR-a gene amplification were as follows: 5'-GCAGACAGAC'ITGTCACTGG-3' and 5'-GCTCTA-GGTCCTGGAGAATG-3'. Primers for the second step of PCR: 5'-GGGTCGACTCTCAGCTGGTACACGGCA-3' and S -G C A T E GG-TGCTATGCTGTGTGTCT-3'.
Primers for the first step of the TCR-P gene amplification were as follows: 5"TGTGCA-3'. primers for the second step of PCR: 5"GGGTCGACACAC-GGTCAAGAGAAAGGA-3'. As indicated by underlines, each primer for the second step of PCR contained Sal I or Nor I site to allow ligation of the amplified fragments into the vectors.
Cloning and sequencing. The amplified DNA fragments were ligated to Phagescript vector (Stratagene, La Jolla, CA) and transfected into Escherichia coli XL-l blue (Stratagene). Singlestranded phage DNA was prepared from randomly selected plaques and was sequenced by dideoxy chain termination method using fluorescein-conjugated universal primers on a 373A-36 DNA sequencer (Applied Biosystems).*' The sequence data were assigned to variable (V), diversity (D) in the case of TCR-P, nucleotides (N) and joining CCTCC'ITCCCA'ITC-3' and 5"CCACCATCCTCTATGAGATC-AGCGACCTCGGGTGGG-3' and 5"GCATGCGGCCGCCAT-(J) regions using sequence analysis software (DNASIS; Hitachi Software Engineering, Yokohama, Japan) with GenBank data base on a personal computer (PC-9801 FA; NEC, Tokyo, Japan). V a , Ja, VD, and JP were categorized according to the published nomenclat~r e . * ' -~~ Double-stranded phage DNA was also prepared and digested with Sal I and Not I to check the size of the cloned TCR gene fragment. In the complete sequence, a poly-A signal sequence derived from mRNA is detected between the C region and signal sequences because of the cDNA circularization followed by the inverse PCR amplification. If the sizes of the amplified gene segments andor poly-A sequences differed between two same TCR sequences, we considered that they were derived from different mRNA or cells.
Cross-contamination was prevented according to the published recommendations throughout this study.34
RESULTS
Characterization of T cells injiltrating the GVHD lesions.
Oral mucosal biopsies were performed on day 52, which was the third day after the onset of mucositis. Samples were obtained from the inside of lower lip (designated as mucosa 1) and from the buccal membrane (mucosa 2). Pathologically, both samples showed liquefaction degeneration of the basal cells, satellite cell necrosis in the epidermis and lymphocyte infiltration, indicating typical acute GVHD. Most of the infiltrating lymphocytes were CD3+CD8+ T cells, and the remainders were CD3+CD4+ T cells (Fig 1) . The cutaneous lesion on the neck (designated as skin) on day 97 was pathologically similar to the mucosal lesions on day 52.
TCR repertoire of donor and patient's PB before allo-BMT. As a control study, we analyzed TCR repertoire of the PB from the donor and the patient before allo-BMT. Forty-three of 46 (93.5%) TCR-a and 43 of 44 (97.7%) TCR-P sequences from the donor PB had productive rearrangements that consisted of complete organization of V-(D)-J-C joining in frame. Three TCR-a transcripts and 5 TCR P transcripts appeared twice in each analysis (Table   1 ). In the patient's PB before allo-BMT (day -lo), 33 of 38 (86.8%) TCR-a and 34 of 37 (91.9%) TCR-/3 sequences were productive, and 5 TCR-a and 3 TCR-P transcripts appeared twice (Table 1 ). The donor PB and the patient's PB showed a similar usage of Va and VP subfamilies (Fig  2) .
None of the TCR transcripts in the patient's PB before allo-BMT was found in the other samples (Tables 2 and 3) .
TCR repertoire in the PB after allo-BMT. We analyzed TCR repertoires in the PB on days 52 and 97 when mucosal and cutaneous biopsies were performed, respectively. Some TCR transcripts were detected more than twice (Table 1) .
Four TCR-a transcripts were found more than twice in the PB on day 52. A Va7-JaQ transcript was detected 12 times, which accounted for 35.3% among the TCR-a sequences in the PB. A Val9-JaIGRJa06 transcript was found 6 times (Fig 2) . On day 97, although three transcripts were noticed more than twice, the usage of Va subfamily became diverse. One of the three recurrent transcripts, V61-JaIGRJal4, was composed of a VS subfamily gene and a Ja gene segment. On the other hand, a Vaw23-JaU transcript on day 97 was also detected in the donor PB (Table  2) .
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There were three TCR-p transcripts found more than twice on day 52 (Table 1) . A Vp8-Jp2.2 transcript of the three was found in the donor PB and also in the patient's PB on day 97. In the PB on day 97, two transcripts were noticed more than twice. A Vp7-Jp2.2 transcript was found 6 times. Three transcripts (Vp5-Jp2.1, Vp7-Jp2.2, Vp8-Jp2.2) on days 52 and 97 were also detected in the donor PB (Table  3) .
TCR repertoire in the GVHD lesions. To elucidate whether some restricted transcripts were associated with the GVHD lesions, we comparatively analyzed TCR repertoires from three lesions: the mucosa 1 and the mucosa 2 on day 52, and the skin on day 97. We analyzed 137 TCR-a and 123 TCR-P sequences from the GVHD lesions, of which 122 (89.1%) and 120 (97.6%), were productive, respectively (Table 1) . There was significant recurrence of the TCR transcripts in the GVHD lesions as well as in the PB. The usage of Va subfamilies in the mucosa 1 and the mucosa 2 was similar (Fig 2) , and there seemed to be no preferential usage of a particular Va subfamily. In the skin on day 97, the usage was highly biased toward the Va-2 subfamily. Furthermore, two transcripts (Va2-JaJ, Va2-JaQ) used not only the same Va gene segment, AA25;" but also a common complementarity determining region (CDR)-3 motif as described below.
In Table 2 , I2 TCR-a transcripts that were found in more than one sample are presented. Six transcripts (Va2-JaN, Va2-JaS, Va8-Ja40, Va 19-JaIGRJa03, Va2 1 -JaAB 1 I , Vaw23-Ja0) were detected in both the mucosas I and 2, whereas only 1 of the 6 (VaI9-JalGRJa03) was found in the PB. A Va12-Jaw transcript was recurrently found in the mucosa 1 and the skin. These data suggest that the TCR a repertoires in the GVHD lesions did not reflect bystanders around the GVHD lesions but were significantly selected.
As to the usage of Vp subfamilies, VD-6 was more frequently used in the skin than in the PB on day 97 (Fig 2) . The usage of Vp subfamilies was essentially similar among three lesions. In Table 3 , TCR-0 transcripts found in more than one sample are presented. In the mucosas 1 and 2, a Vp 13-Jp 1.1 transcript was recurrent. Two transcripts (Vp6-Jp2.7, Vp19-Jp2.2) were detected in the mucosa 2 and the PB on the same day. There were two transcripts (Vp6-J02.7, Vp7-Jp2.1) found in the mucosa 1 or 2, and the skin.
The TCR repertoires in mucosal and cutaneous lesions differed from each other except for one TCR-a and two TCR-P transcripts (Va I2-JaW, Vp6-JB2.7, Vp7-Jp2.1).
In Table 4 , TCR a transcripts with common motifs of CDR-3 in the infiltrating T cells are presented. Two transcripts (Va2-JaS, Va2-JaJ) in the lesions shared a common CDR-3 motif, VNSP, whereas the Va2-JaJ transcript shared another motif, G***G*L*F with a Va2-JaQ transcript. Furthermore, a Va4-JaG transcript in the mucosa 2 and a Va4-JaV transcript in the mucosa 1 had another CDR-3 motif, LRD, and both used the same Va gene segment, HAP 08.3 ' In Table 5 , TCR-P transcripts with common motifs of CDR-3 in the infiltrating T cells are presented. Two transcripts (Vp5-Jp2.3, Vp5-Jp2.5) from the skin shared a common motif of CDR-3, GSLG, and the same Vp gene seg- ment, HBP5 1 .33 A Vp6-Jp2.7 transcript from the mucosa l and a different Vp6-Jp2.7 transcript from the skin had a common motif, SPoGAGV, and they used the same Vp gene segment, HBVT45.32 Two transcripts (Vp5-Jp2.4, Vp13-Jp2.4) and another two transcripts (Vp6-Jp2.7, Vp19-Jp2.7) from the skin were common in LAGGP and TGGA, respectively, but were different in the usage of Vp gene segment.
DISCUSSION
In this study, we directly analyzed the TCR repertoires in the GVHD lesions and the PB to investigate the significant T cells in GVHD. For the cloning of TCR transcripts by conventional RT-PCR, a panel of V subfamily-specific primers need to be prepared besides the C region primer."335 However, a novel V subfamily, that differs in sequence from the primers, cannot be identified and the efficiency of amplification with each primer set differs to quantify the starting amounts of mRNA. Inverse PCR has advantages for TCR repertoire a n a l y~i s .~~.~~ Because only one set of primers corresponding to the C region of TCR is needed for PCR, procedural inconvenience and bias of amplification are minimized. Using this method, we noticed that some TCR transcripts were detected twice even in normal PB from donor. There might be a limited kind of TCR transcripts andor skewed expansion of T-cell clones in normal PB. Clonal population of T cells has been reported in PB from normal elderly humans.36 Alternatively, there might be an experimental preference for some sequences during the PCR amplification. However, the remarkable recurrence of a TCR transcript with different sizes of amplified gene segments andor poly-A sequences would indicate the significant expansion of a T-cell clone, because no TCR transcript appeared more than twice in normal PB under the same experimental condition. The data on TCR repertoire obtained by the PCR method need to be confirmed by a serological method using V subfamily-specific antibodie~.~~ First of the notable findings in this study is that the TCRa repertoire in the PB at the initial onset of GVHD showed oligoclonal expansion, whereas the TCR-P repertoire on the same day did not. During reconstitution of the T-cell system after BMT, the TCR repertoire is thought not to be proportionally expanded but to be influenced by various factors such as viral, bacterial, or fungal infections. Oligoclonal Tcell expansion has been often observed after auto-and allo-BMT without GVHD." Therefore, we suppose that the skewed repertoire early after BMT does not necessarily reflect acute GVHD. The TCR-a repertoire in the PB at the second onset of GVHD became diverse, suggesting polyclonal expansion during lymphoid reconstitution. The presence of the VS-Ja joining transcript, which has been reported,29 might indicate a new recombination of the TCR gene in lymphoid stem cells from the transplanted BM.
Secondly, the TCR repertoires in the lesions differed from those in the PB at the same time, and some TCR transcripts were significantly recurrent in more than one GVHD lesion. Dietrich et alls have reported selectively amplified TCR transcripts in both cutaneous lesion and PB at time of acute GVHD onset. Our data partly supported their findings as to the clonal T-cell expansion in GVHD, but indicated that most of the recurrent TCR transcripts in the GVHD lesions were not found in the PB. In the mild GVHD as this case, these lesion-specific TCR transcripts might be associated with GVHD. However, it is important to consider the possibility that the TCR repertoire of infiltrating T cells may be primarily selected in a tissue-specific manner. 38 Comparison of the TCR repertoires in the GVHD lesions with those in oral mucosa and skin before allo-BMT and those of unaffected areas at time of GVHD onset would further unmask T-cell clones associated with GVHD, although it is difficult to obtain enough TCR transcripts from such samples.
On the other hand, this study showed that the TCR repertoires in mucosal and cutaneous lesions differed from each other except for one TCR-a and two TCR-P transcripts. This difference might be induced by the following factors: tissue specificity of allo-antigens, timing of the biopsy, normal bacterial flora, secondary infections, and/or the administration of prednisolone.
Finally, some recurrent TCR transcripts in the lesions had common CDR-3 motifs as well as the same or similar V gene segments. Study using in situ hybridization to characterize the TCR idiotype would provide deeper insight into the TCR repertoire in GVHD. 39 In the third-dimensional model of the TCR-MHC interaction, CDR-1 and -2 of TCR are attached on two a-helix domains of the MHC molecule, and CDR-3 binds the peptide presented between the two ahelix domains. The CDR loops physically interact and form binding site for an MHC-peptide complex. Conservation of CDR-3 motif among TCR transcripts suggests that they recognize the same or similar peptides. Myelin basic protein (MBP)-associated T cells from patients with multiple sclerosis, for example, use the common motif of CDR-3 as well as a particular V/3 subfamily:" suggesting that these are reactive to a common target peptide of MBP. On the other hand, the HLA-mismatched allo-reactive T cells do not necessarily use restricted Va or Vp subfamilies, and moreover use highly varied CDR-3;' suggesting that they recognize not only MHC molecules but also various endogenous peptides presented by MHC molecules. Therefore, we believe For personal use only. on October 31, 2017. by guest www.bloodjournal.org From that the recurrent TCR transcripts sharing CDR-3 motifs recognize not random peptides, but a limited kind of antigen that is presented by the target organs of GVHD.
Because clinical manifestation of acute GVHD is usually observed in oral mucosa and skin, there might be a preferential expression of some minHAs or virus-associated antigens in these tissues." In that case, cultured epithelial cells might be a better target than PB mononuclear cells for allo-reactive assay in v i t r~. "~"~ In the future, it will be necessary to determine whether the recurrent TCR transcripts in the lesions are directed to alloantigens. For this purpose, functional assay and TCR analysis using the cloned T cells from the GVHD lesions would be needed. On the other hand, because our data suggested that limited but various peptides were recognized by multiple T-cell clones, the prevention of GVHD by selective T-cell depletion using the V subfamilyspecific or CDR-3-specific antibodies remains a complex issue.
